Inventor · disambiguated record
William J. Smith
Also filed as: SMITH WILLIAM J · SMITH WILLIAM JAMES
6 granted patents·14 pending applications·14 citations·filing 2011–2024
77Inventor score
Files withMERCK SHARP & DOHME LLC11MERCK SHARP & DOHME6BHAMBHANI AKHILESH1BLUE JEFFREY T1SMITH WILLIAM J1
Top patents by PatentIndex Score
20 records- 0195US11850278B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 26, 2023·3 cites·2 claims
- 0293US11116828B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME·Filed 2018·Granted Sep 14, 2021·7 cites·49 claims
- 0386US11090374B2Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Aug 17, 2021·3 cites·14 claims
- 0485US12097250B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Granted Sep 24, 2024·0 cites·9 claims
- 0583US2024398925A1Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 0676US12280107B2Pneumococcal conjugate vaccine formulationsMERCK SHARP & DOHME LLC·Filed 2023·Granted Apr 22, 2025·0 cites·2 claims
- 0772US2023234850A1Adjuvanted vaccinesMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0871US11219680B2Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrierMERCK SHARP & DOHME·Filed 2018·Granted Jan 11, 2022·1 cites·10 claims
- 0970US2024408188A1Nanoemulsion adjuvant compositions for human papillomavirus vaccinesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1069US2021330777A1Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugatesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 1169US2021330778A1Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugatesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 1267US2023192489A1Adjuvanted vaccinesMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1366US2024390471A1Compounds and adjuvant formulations useful in pneumococcal vaccinesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1466US2025255948A1Pneumococcal conjugate vaccines and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1564US2022031837A1Pneumococcal conjugate vaccine formulationsMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 1658US2024108710A1Nanoemulsion adjuvant composition for pneumococcal conjugate vaccinesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1757US2024123047A1Lipid nanoparticle adjuvant composition for pneumococcal conjugate vaccinesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1851US2020325020A1Adjuvanted vaccinesBHAMBHANI AKHILESH·Filed 2018·Application pending·0 cites
- 1949US2020054740A1Pneumococcal conjugate vaccine formulationsSMITH WILLIAM J·Filed 2018·Application pending·0 cites
- 2035US2013273098A1Novel formulations which mitigate agitation-induced aggregation of immunogenic compositionsBLUE JEFFREY T·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William J. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →